Pieris Pharmaceuticals, INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
Palvella Therapeutics files an amendment to its registration statement for the potential resale of up to 5,634,504 shares of its common stock by selling stockholders.
Palvella Therapeutics, Inc. has filed a registration statement for the resale of up to 5.6 million shares of its common stock following its recent merger with Pieris Pharmaceuticals.